Distinguished Investigator Grant within Endocrinology and Metabolism – Nordic Region supports professors' basic and clinical research to understand disease and improve treatment or prevention.
Funder: Novo Nordisk Foundation
Due Dates: January 19, 2027, 2:00pm Copenhagen time (Application) | May 2027 (Results) | June 1, 2027 (Earliest start) | May 31, 2028 (Latest start)
Funding Amounts: Up to DKK 12.5 million over five years per grant; up to two grants from DKK 25 million
Summary: Supports outstanding professors leading ambitious Nordic research into endocrinology and metabolism to understand disease and improve treatment or prevention.
Key Information: Applicants’ annual external grant portfolio must not exceed DKK 5 million, excluding overhead, in the project’s starting year.
The Novo Nordisk Foundation supports outstanding professors who have demonstrated sustained research leadership at the highest international level. This individual investigator grant funds ambitious basic and clinical research into the human organism, cellular energy homeostasis, and hormonal disorders, aiming to generate knowledge and improve disease treatment or prevention.
Projects may involve patients, clinical practice, animal models, model organisms, cellular or sub-cellular systems with clear whole-body relevance, or in silico analysis. All endocrinology subfields are eligible, including thyroid research, reproduction, and bone and calcium metabolism—not only diabetes. Cancer research is excluded, although endocrine tumour projects focused on signalling or crosstalk rather than cancer development may be considered.